AUXILIUM PHARMACEUTICALS INC: 10-Q filed 2010-08-06
What AUXILIUM PHARMACEUTICALS INC reported in its quarterly report filed 2010-08-06 (fiscal Q2 2010): 29 published measures, 70 facts as tagged in accession 0001193125-10-181124.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2010-08-06
- Fiscal period
- fiscal Q2 2010
- Accession
- 0001193125-10-181124 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All AUXILIUM PHARMACEUTICALS INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 264,443,000 | USD | |
| At 2009-12-31 | 260,564,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 112,274,000 | USD | |
| At 2009-12-31 | 120,519,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 165,010,000 | USD | |
| At 2009-12-31 | 181,977,000 | USD | |
| At 2009-06-30 | 80,352,000 | USD | |
| At 2008-12-31 | 113,943,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | -13,471,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -22,080,000 | USD | 181 |
| 2009-04-01 to 2009-06-30 | -13,374,000 | USD | 91 |
| 2009-01-01 to 2009-06-30 | -26,608,000 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | -16,396,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | -29,399,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | 5,388,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | 6,253,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | 4,240,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | 2,025,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | -4,788,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | -6,253,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | -345,992,000 | USD | |
| At 2009-12-31 | -323,912,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | 47,327,751 | shares | 91 |
| 2010-01-01 to 2010-06-30 | 47,230,671 | shares | 181 |
| 2009-04-01 to 2009-06-30 | 42,008,009 | shares | 91 |
| 2009-01-01 to 2009-06-30 | 42,399,560 | shares | 181 |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2009-04-01 to 2009-06-30 | 317,000 | USD | 91 |
| 2009-01-01 to 2009-06-30 | 631,000 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 26,921,000 | USD | |
| At 2009-12-31 | 24,227,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | 8,422,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | 9,400,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | -13,420,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | -21,973,000 | USD | 181 |
| 2009-04-01 to 2009-06-30 | -13,162,000 | USD | 91 |
| 2009-01-01 to 2009-06-30 | -26,300,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 224,747,000 | USD | |
| At 2009-12-31 | 224,790,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | 91,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 182,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 64,076,000 | USD | |
| At 2009-12-31 | 63,376,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 4,894,000 | USD | |
| At 2009-12-31 | 6,711,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 21,226,000 | USD | |
| At 2009-12-31 | 18,266,000 | USD |
Common-stock repurchase payments
Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | 216,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | 575,000 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 35,508,000 | USD | |
| At 2009-12-31 | 19,554,000 | USD |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | 41,228,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 77,331,000 | USD | 181 |
| 2009-04-01 to 2009-06-30 | 29,383,000 | USD | 91 |
| 2009-01-01 to 2009-06-30 | 55,785,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-04-01 to 2010-06-30 | 11,142,000 | USD | 91 |
| 2010-01-01 to 2010-06-30 | 19,621,000 | USD | 181 |
| 2009-04-01 to 2009-06-30 | 13,734,000 | USD | 91 |
| 2009-01-01 to 2009-06-30 | 27,267,000 | USD | 181 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | -671,000 | USD | |
| At 2009-12-31 | -781,000 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 112,274,000 | USD | |
| At 2009-12-31 | 120,519,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 10,122,000 | USD | |
| At 2009-12-31 | 8,429,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2010-06-30 | 52,432,000 | USD | |
| At 2009-12-31 | 51,571,000 | USD |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | 2,887,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | 1,736,000 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2010-01-01 to 2010-06-30 | -14,891,000 | USD | 181 |
| 2009-01-01 to 2009-06-30 | -4,000 | USD | 181 |
Inspect the source
- Entity
- AUXILIUM PHARMACEUTICALS INC / CIK 0001182129
- Captured
- SEC response SHA-256
a43aa0c94dd494172c2977e107d1d545682ca42fca3434a6fc01412765902185
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001182129.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))